Le Lézard
Classified in: Health
Subjects: AWD, WOM

Recovery Unplugged to be Featured in USA Today for "Three Moms" Campaign


FORT LAUDERDALE, Fla., Sept. 9, 2018 /PRNewswire/ -- Recovery Unplugged Treatment Centers is pleased to announce that they will be featured in USA Today's upcoming Addiction and Mental Health Awareness Issue. The organization will be featured for their inspiring and innovative "Three Stories" campaign, a multimedia marketing effort that tells the stories of three mothers who helped their children, all current Recovery Unplugged staff members, overcome addiction and take their lives back from drugs and alcohol.

Three moms. Three children. Three stories of success. Recovery Unplugged brought in the mothers of three employees to hear their stories of struggle, sorrow, and success.

The stories in this campaign serve as an illuminating and inspirational reminder of the incredible power of family, and a must-read for any parent, loved one or friend of someone struggling with substance use disorder. Last year over 72,000 people died from drug overdose and Recovery Unplugged wants to remind families, communities and loved ones of vulnerable SUD sufferers that they have the power to affect change.

USA Today's Addiction and Mental Health Awareness Issue will be released on Thursday, September 13th. For more information on the campaign and Recovery Unplugged, contact Vicki Quintero at [email protected].

About Recovery Unplugged

Recovery Unplugged is a national addiction treatment organization, and the only addiction care provider to fully integrate music into our rehab programs. Combining traditional treatment resources like medical detox, comprehensive behavioral rehab and aftercare with innovative and effective music-based therapies, Recovery Unplugged offers clients an effective, unique and music-focused treatment experience. Our world-class doctors, therapists and creative professionals leverage the power of music to help our clients heal from drugs and alcohol and reclaim their lives from addiction. This music-based treatment approach has helped clients from all over the country access their confidence, break down emotional barriers and overcome their addictions.

Contact: Dominic Nicosia
[email protected] 
Phone: (732) 766-0246

SOURCE Recovery Unplugged


These press releases may also interest you

at 07:05
Executive War College to Address, Clinical Laboratories' and Genetic Testing Firms' Perfect Storm, involving FDA's Proposed LDT Rule, Payers Requiring Z-Codes on Genetic Test Claims, and Revisions to CLIA Regulations
Three major challenges poised to confront the nation's clinical laboratories, genetic test companies, and anatomic pathology laboratories will be major topics when a top-flight roster of lab experts, innovators, and lab leaders gather in New Orleans...

at 07:05
Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1
Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that second quarter of fiscal year 2024 financial results will be released before the market opens on Wednesday,...

at 07:04
Health Canada Approves KEYTRUDA® as a first-line treatment for adult patients with locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma in combination with fluoropyrimidine- and platinum-containing chemotherapy
Merck , known as MSD outside the United States and Canada, announced that Health Canada has granted approval of  KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in combination with fluoropyrimidine- and platinum-containing-chemotherapy, for the...

at 07:00
GLOBE LIFE INC. ANNOUNCES FIRST QUARTER 2024 EARNINGS RELEASE AND CONFERENCE CALL
Globe Life Inc. will release First Quarter 2024 earnings after the market closes on Monday, April 22, 2024.  At that time, a copy of the Company's First Quarter 2024 earnings press release and any other financial and statistical information about...

at 07:00
GenFleet Therapeutics Announces FDA's Clinical Trial Approval for GFH925 (KRAS G12C Inhibitor) Monotherapy in Phase III Registrational Study Treating Metastatic Colorectal Cancer
GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug Administration (FDA) has granted the clinical trial approval for GFH925 (KRAS G12C inhibitor) in a...

at 07:00
Drug-Free Pain Relief Comes in the Form of Red Laser Therapy
César A. Lara, MD, introduces a groundbreaking solution for pain relief in the Tampa Bay area. Red Laser Therapy leverages the power of medical-grade red laser light to effectively address various types of pain, providing patients with a noninvasive...

More news about Health...


News published on and distributed by: